X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23) 23
index medicus (23) 23
female (19) 19
male (18) 18
aged (12) 12
life sciences (12) 12
middle aged (11) 11
abridged index medicus (9) 9
adult (8) 8
chemotherapy (7) 7
patients (7) 7
cancer (6) 6
carcinoma, non-small-cell lung - mortality (6) 6
lung cancer (6) 6
lung cancer, non-small cell (6) 6
lung neoplasms - mortality (6) 6
oncology (6) 6
treatment outcome (6) 6
animals (5) 5
carcinoma, non-small-cell lung - drug therapy (5) 5
care and treatment (5) 5
lung neoplasms - drug therapy (5) 5
prognosis (5) 5
risk factors (5) 5
analysis (4) 4
cancer therapies (4) 4
carcinoma, non-small-cell lung - pathology (4) 4
follow-up studies (4) 4
lung neoplasms - pathology (4) 4
mesh : female (4) 4
mesh : humans (4) 4
prospective studies (4) 4
respiratory system (4) 4
retrospective studies (4) 4
studies (4) 4
surgery (4) 4
usage (4) 4
[ sdv ] life sciences [q-bio] (3) 3
adolescent (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
apnea (3) 3
article (3) 3
carcinoma, non-small-cell lung - therapy (3) 3
cell biology (3) 3
child, preschool (3) 3
clinical trials (3) 3
cytokines (3) 3
disease (3) 3
disease-free survival (3) 3
docetaxel (3) 3
health aspects (3) 3
hematology, oncology and palliative medicine (3) 3
hospitals (3) 3
immunoglobulin g (3) 3
immunotherapy (3) 3
infant, newborn (3) 3
infant, premature (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
medicine, general & internal (3) 3
mesh : adult (3) 3
mesh : male (3) 3
mesh : middle aged (3) 3
mesh : treatment outcome (3) 3
mutation (3) 3
nsclc (3) 3
original (3) 3
pediatrics (3) 3
physics (3) 3
prematurity (3) 3
regression analysis (3) 3
therapy (3) 3
time factors (3) 3
tumors (3) 3
young adult (3) 3
[ sdv.bc ] life sciences [q-bio]/cellular biology (2) 2
[ sdv.can ] life sciences [q-bio]/cancer (2) 2
[sdv.bc]life sciences [q-bio]/cellular biology (2) 2
[sdv.can]life sciences [q-bio]/cancer (2) 2
[sdv]life sciences [q-bio] (2) 2
aged, 80 and over (2) 2
antibodies, monoclonal - adverse effects (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
apoptosis (2) 2
autolysosome (2) 2
autophagosome (2) 2
bayesian analysis (2) 2
biomarkers (2) 2
blockade (2) 2
caffeine therapy (2) 2
cancer vaccines - adverse effects (2) 2
cancer vaccines - therapeutic use (2) 2
carcinoma, non-small-cell lung - genetics (2) 2
cardiac & cardiovascular systems (2) 2
cellular biology (2) 2
chaperone-mediated autophagy (2) 2
child development (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 257 - 265
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10026, pp. 1415 - 1426
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1125 - 1133
Summary Background Chemotherapy is the standard of care for advanced stages of non-small-cell lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on... 
Hematology, Oncology and Palliative Medicine | DOUBLE-BLIND | PROGNOSTIC-FACTORS | GENE | ONCOLOGY | EXPRESSION | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Vaccinia virus - genetics | Antimetabolites, Antineoplastic - administration & dosage | Cisplatin - administration & dosage | Cancer Vaccines - therapeutic use | Interleukin-2 - immunology | Time Factors | Adult | Female | Chemotherapy, Adjuvant | Carcinoma, Non-Small-Cell Lung - pathology | Risk Assessment | Deoxycytidine - administration & dosage | Europe | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Cancer Vaccines - adverse effects | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - immunology | Disease-Free Survival | Interleukin-2 - genetics | Carcinoma, Non-Small-Cell Lung - therapy | Lung Neoplasms - immunology | Membrane Glycoproteins - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mucin-1 - immunology | Vaccines, Synthetic | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Membrane Glycoproteins - adverse effects | Deoxycytidine - analogs & derivatives | Mucin-1 - genetics | Index Medicus | Interleukin-2 | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Life Sciences | Cancer Vaccines | Membrane Glycoproteins | Antineoplastic Combined Chemotherapy Protocols | Cisplatin | Mucin-1 | Vaccinia virus | Deoxycytidine | Antimetabolites, Antineoplastic | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 212 - 223
Summary Background MUC1 is a tumour-associated antigen expressed by many solid tumours, including non-small-cell lung cancer. TG4010 is a modified vaccinia... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | MVA-MUC1-IL2 | PROSTATE-CANCER | VACCINE | Predictive Value of Tests | Carcinoma, Non-Small-Cell Lung - chemistry | Humans | Middle Aged | Fatigue - etiology | Male | Cisplatin - administration & dosage | Antigens, CD - analysis | Antigens, Differentiation, T-Lymphocyte - analysis | Neutropenia - etiology | Cancer Vaccines - therapeutic use | Receptors, IgG - analysis | Mucin-1 - analysis | Lectins, C-Type - analysis | Female | Paclitaxel - administration & dosage | Lymphocytes - chemistry | Anemia - etiology | Bevacizumab - administration & dosage | Double-Blind Method | Lung Neoplasms - chemistry | Lymphocyte Activation | CD56 Antigen - analysis | Deoxycytidine - administration & dosage | Erlotinib Hydrochloride - administration & dosage | Carboplatin - administration & dosage | Cancer Vaccines - adverse effects | Lung Neoplasms - therapy | Immunotherapy - adverse effects | Biomarkers, Tumor - blood | Disease-Free Survival | Carcinoma, Non-Small-Cell Lung - therapy | Membrane Glycoproteins - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pemetrexed - administration & dosage | Aged | Membrane Glycoproteins - adverse effects | Deoxycytidine - analogs & derivatives | Antigens | Fc receptors | Hospitals | Interleukins | Immunotherapy | Mucins | Clinical trials | Product development | Lung cancer, Non-small cell | Analysis
Journal Article
Annals of Thoracic Surgery, ISSN 0003-4975, 2011, Volume 92, Issue 1, pp. 297 - 301
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 5, pp. 510 - 519
Summary Background Listeriosis is a severe foodborne infection and a notifiable disease in France. We did a nationwide prospective study to characterise its... 
Infectious Disease | MORTALITY | MENINGITIS | INFECTIOUS DISEASES | MONOCYTOGENES | RISK-FACTORS | MANAGEMENT | GUIDELINES | SURVEILLANCE | PREGNANCY | Foodborne Diseases - microbiology | Infant, Newborn, Diseases - epidemiology | Prognosis | Prospective Studies | Humans | Listeriosis - diagnosis | Bacteremia - mortality | Male | Infant, Newborn, Diseases - microbiology | Listeriosis - epidemiology | Mandatory Reporting | Listeria monocytogenes - classification | Adult | Female | Pregnancy Complications, Infectious - microbiology | Infant, Newborn | Meningoencephalitis - epidemiology | France - epidemiology | Meningoencephalitis - mortality | Pregnancy Complications, Infectious - epidemiology | Risk Factors | Listeria monocytogenes - isolation & purification | Hospitalization | Infectious Disease Transmission, Vertical | Pregnancy | Meningoencephalitis - microbiology | Bacteremia - epidemiology | Listeriosis - microbiology | Aged | Population Surveillance | Listeriosis | Neonates | Food-borne diseases | Disease | Brain stem | Clinical trials | Infections | Genomes | Gestation | Epidemiology | Risk factors | Windows (intervals) | Listeria | Meningitis | Public health | Food | Dexamethasone | Bacterial infections | Mortality | Fetuses | Regression analysis | Clustering | Patients | Bacteremia | Meningoencephalitis | Studies | Surveillance | Medical prognosis | Health risk assessment | Cancer | Life Sciences
Journal Article